Perfusion Bioreactor for Continuous GLP-1 Peptide Secretion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing recombinant Glucagon-like peptide-1 (GLP-1) using bacteria are not efficient for continuous production and secretion, lacking effective purification and secretion enhancement techniques.
Innovation Solution
A method involving a novel bacterial expression vector with a DNA sequence encoding GLP-1, a secretory signal sequence, and an affinity tag for purification, combined with a perfusion-based fermentation system and alternating tangential filtration for continuous production and secretion of recombinant GLP-1 peptide in E. coli.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional batch fermentation is used for GLP-1 production, then the process is simple to operate, but the production rate and secretion efficiency are low
Solution Approach 1:
The patent transitions from static batch fermentation to dynamic perfusion fermentation, where fresh media continuously replaces spent media and cells are retained in the bioreactor. This dynamic operation maintains high cell density and metabolic activity, achieving production rates of 1-1.2 g/L/hr compared to traditional batch methods
Solution Approach 2:
The perfusion system enables continuous production by constantly supplying fresh nutrients and removing waste products. The continuous flow regime maintains optimal growth conditions throughout the fermentation process, eliminating the productivity decline seen in batch cultures after exponential growth phase
2Productivity
If GLP-1 is produced intracellularly, then the expression yield is high, but the purification process is complex and time-consuming
Solution Approach 1:
The patent extracts the GLP-1 peptide from intracellular location to extracellular medium through engineered secretion pathways. The inclusion of signal sequences (pelB, ompA, yebF, ompF) directs the peptide across the bacterial membrane, allowing direct harvesting from fermentation broth and eliminating complex cell lysis and purification steps
Solution Approach 2:
Signal sequences act as intermediaries between the GLP-1 coding sequence and the bacterial secretion machinery. These peptide leaders facilitate transport across the membrane, serving as a bridge that enables extracellular accumulation without requiring complex purification infrastructure
3Speed
If complex media is used for bacterial growth, then the growth rate is high, but the downstream purification becomes difficult
Solution Approach 1:
The patent changes the chemical composition parameters of the growth media from complex undefined formulations to chemically defined compositions. This parameter change maintains adequate growth rates while eliminating interfering substances that complicate downstream purification, allowing direct harvesting of secreted GLP-1
4Productivity
If secretion signal sequences are added to the expression vector, then the secretion efficiency increases, but the vector complexity increases
Solution Approach 1:
The expression vector is segmented into functional modules: promoter region, ribosome binding site, coding sequence with signal peptide, affinity tag, and terminator. This modular segmentation allows systematic optimization of secretion while maintaining manageable vector complexity through standardized genetic elements
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables high-rate production and secretion of recombinant GLP-1 peptide, with secretion rates up to 1-1.2 g/L/hr, and efficient purification using a chemically defined media and hollow fiber filtration system.
Implementation Method 1
initiating perfusion-based fermentation system after 30-40 mins of induction for separating the recombinant E. coli as retentate from the spent culture media containing the secreted recombinant GLP-1 peptide as permeate
Data Source
AI summary
The invention relates to a method for continuously producing and secreting recombinant Glucagon-like peptide-1 (GLP-1) by bacteria, more specifically E. coli. More specifically, the invention relates to use of novel bacterial expression vector for producing and enabling extracellular secretion of GLP-1, use of novel media composition for enhancing the secretion and enabling purification, and a perfusion-based fermentation system for continuous production and separation of recombinant GLP-1 peptide.